Presentation of HEALEY ALS Platform Trial - Open Label Extension Results at 2024 ENCALS Meeting
Jun 18, 2024
Clene Nanomedicine, Inc. is a wholly owned subsidiary of Clene Inc. | © 2024 Clene Nanomedicine, Inc. - All rights reserved | PRIVACY POLICY | TERMS OF USE